Literature DB >> 15113392

Evidence of macrophage and lymphocyte, but not dendritic cell, infiltration in posterior uveal melanomas, whilst cultured uveal melanomas demonstrate pluripotency by expressing CD68 and CD163.

Julia Woodward1, Karen Sisley, Graham Reeves, Carmel Nichols, M Andrew Parsons, Hardeep Mudhar, Ian Rennie.   

Abstract

Although variation in the level of macrophage infiltration has been reported in uveal melanoma, little is known about the expression of other leucocyte markers. An immuno- histochemistry study of the levels of expression of macrophage and other leucocyte markers, in a series of 10 primary choroidal melanoma biopsies, was undertaken. Biopsies were either fixed immediately in formalin and embedded in paraffin wax or established as short-term cultures. Using single- and double-labelling immunohistochemistry, cultured cells and paraffin sections were analysed for a range of melanoma (HMB45, Melan A, S100 and tyrosinase) and immune cell (CD68, CD163, CD45 and CD1a) markers. All samples expressed at least two known melanoma markers. Infiltrating macrophages were present in the majority of sections. When cultured specimens were studied by double-labelling immunofluorescence, uveal melanoma cells were seen to express macrophage markers or have cross-reactivity with related proteins. Expression of the leucocyte antigen CD45 was observed in three tumours but was not present in any cultured cells, whilst the expression of the dendritic cell marker CD1a was absent from all samples.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15113392      PMCID: PMC2517456          DOI: 10.1111/j.0959-9673.2004.00370.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  27 in total

Review 1.  Macrophage-specific gene expression: current paradigms and future challenges.

Authors:  David R Greaves; Siamon Gordon
Journal:  Int J Hematol       Date:  2002-07       Impact factor: 2.490

2.  "Histiocytic markers" in melanoma.

Authors:  N L Pernick; M DaSilva; M D Gangi; J Crissman; V Adsay
Journal:  Mod Pathol       Date:  1999-11       Impact factor: 7.842

3.  Expression of integrins, degradative enzymes and their inhibitors in uveal melanoma: differences between in vitro and in vivo expression.

Authors:  J K Baker; S R Elshaw; G E Mathewman; C E Nichols; A K Murray; M A Parsons; I G Rennie; K Sisley
Journal:  Melanoma Res       Date:  2001-06       Impact factor: 3.599

4.  Prognostic factors in uveal melanoma.

Authors:  A D Singh; C L Shields; J A Shields
Journal:  Melanoma Res       Date:  2001-06       Impact factor: 3.599

Review 5.  Biological implications of macrophage infiltration in human tumor angiogenesis.

Authors:  M Ono; H Torisu; J Fukushi; A Nishie; M Kuwano
Journal:  Cancer Chemother Pharmacol       Date:  1999       Impact factor: 3.333

6.  Expression of Fas and Fas ligand in uveal melanoma: biological implication and prognostic value.

Authors:  G Anastassiou; S E Coupland; A Stang; R Boeloeni; H Schilling; N Bornfeld
Journal:  J Pathol       Date:  2001-08       Impact factor: 7.996

7.  Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma.

Authors:  T Mäkitie; P Summanen; A Tarkkanen; T Kivelä
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-06       Impact factor: 4.799

8.  Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases.

Authors:  S A Pileri; T M Grogan; N L Harris; P Banks; E Campo; J K C Chan; R D Favera; G Delsol; C De Wolf-Peeters; B Falini; R D Gascoyne; P Gaulard; K C Gatter; P G Isaacson; E S Jaffe; P Kluin; D M Knowles; D Y Mason; S Mori; H-K Müller-Hermelink; M A Piris; E Ralfkiaer; H Stein; I-J Su; R A Warnke; L M Weiss
Journal:  Histopathology       Date:  2002-07       Impact factor: 5.087

9.  Uveal melanoma cell staining for CD34 and assessment of tumor vascularity.

Authors:  Xue Chen; Andrew J Maniotis; Dibyen Majumdar; Jacob Pe'er; Robert Folberg
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-08       Impact factor: 4.799

10.  Spontaneously formed tumorigenic hybrids of Meth A sarcoma and macrophages grow faster and are better vascularized than the parental tumor.

Authors:  Lill-Tove R Busund; Mette K Killie; Kristian Bartnes; Rolf Seljelid
Journal:  Int J Cancer       Date:  2002-08-01       Impact factor: 7.396

View more
  6 in total

1.  Immune oppression array elucidating immune escape and survival mechanisms in uveal melanoma.

Authors:  Fang Hou; Qi-Ming Huang; Dan-Ning Hu; Jost B Jonas; Wen-Bin Wei
Journal:  Int J Ophthalmol       Date:  2016-12-18       Impact factor: 1.779

2.  A novel in vitro model of human mesothelioma for studying tumor biology and apoptotic resistance.

Authors:  Ki-Up Kim; Shannon M Wilson; Keith S Abayasiriwardana; Rodney Collins; Lars Fjellbirkeland; Zhidong Xu; David M Jablons; Stephen L Nishimura; V Courtney Broaddus
Journal:  Am J Respir Cell Mol Biol       Date:  2005-08-25       Impact factor: 6.914

Review 3.  Tumour-associated macrophages and melanoma tumourigenesis: integrating the complexity.

Authors:  Mahmoud R Hussein
Journal:  Int J Exp Pathol       Date:  2006-06       Impact factor: 1.925

4.  Presence and phenotype of dendritic cells in uveal melanoma.

Authors:  Marta E Polak; Nicola J Borthwick; Penny Johnson; John L Hungerford; Bernie Higgins; Silvana Di Palma; Martine J Jager; Ian A Cree
Journal:  Br J Ophthalmol       Date:  2007-03-08       Impact factor: 4.638

5.  Clinical and cytogenetic characteristics of choroidal melanoma in Vietnamese Asians.

Authors:  Tara A McCannel; Melinda Y Wu; Barry L Burgess
Journal:  Mol Vis       Date:  2011-01-21       Impact factor: 2.367

6.  Isolated Intraocular Rosai-Dorfman Disease.

Authors:  Franz Fogt; Thomas Rüediger; Albert J Augustin; Dale M Frank; Andreas Rosenwald; Axel Wellmann; Vivian Lee
Journal:  Ocul Oncol Pathol       Date:  2019-04-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.